Simvastatin treatment has not significantly improved growth in a randomised phase 3 trial of children with Noonan syndrome (NS), French researchers report in eClinicalMedicine.
Temple syndrome (TS14) has a broader range of phenotypic features than previously recognised and the presentation may change with increasing age, indicates an analysis of children attending two European referral centres.
International guidance has been published on managing the transition of children with endocrine disorders from paediatric to adult services, and on the use of genetic testing in children with short stature.
Basket trial findings indicate that vosoritide therapy may improve growth in children with short stature related to rare genetic disorders of the Ras–mitogen-active protein kinase pathway.
We are delighted to welcome you to the 12th Insights into MAnaging Growth for Endocrine nurses (IMAGE) November 2026 Meeting, organised by Springer Health+ IME. This event will be dedicated to the loving memory of Professor Martin Savage and will take place on 5–6 November 2026 in the beautiful and historic city of Seville in Spain.
The UK Achondroplasia Network has developed consensus guidelines on multidisciplinary care of children and young people with achondroplasia from diagnosis until adulthood.
Glucose–insulin impairment in small-for-gestational-age children is comparable to that found in children with obesity and worsened by use of growth hormone therapy, say German researchers.
Treatment with a C-type natriuretic peptide prodrug significantly increases annualised growth velocity in children with achondroplasia and offers additional health benefits, say the APPROACH trial investigators.
US researchers have created age- and sex-adjusted growth charts for use in children with classic congenital adrenal hyperplasia, reflecting the distinct patterns of height and weight among patients versus the general population.
Italian clinicians have published a set of consensus statements on the multidisciplinary diagnosis, care and treatment of patients with Noonan syndrome from childhood and beyond.
